Resonance Health Ltd Statistics
Want to see AU:RHT full AI Analyst Report?
Resonance Health Ltd (RHT) Stock Statistics & Valuation Metrics
Total Valuation
Resonance Health Ltd has a market cap or net worth of AUD 51.56M. The enterprise value is AUD 19.92M.
- Market Cap
- AUD 51.56M
- Enterprise Value
- AUD 19.92M
Share Statistics
Resonance Health Ltd has 560,453,550 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 560,453,550
- Owned by Insiders
- 14.32%
- Owned by Institutions
- ―
Financial Efficiency
Resonance Health Ltd’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 10.26%.
- Return on Equity (ROE)
- 0.14
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- 10.26%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 875.11K
- Profits Per Employee
- 84.06K
- Employee Count
- 18
- Asset Turnover
- 0.84
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Resonance Health Ltd is 27.50. Resonance Health Ltd’s PEG ratio is 0.07.
- PE Ratio
- 27.50
- PS Ratio
- 3.13
- PB Ratio
- 3.77
- Price to FCF
- 17.70
- Price to Operating Cash Flow
- 14.55
- PEG Ratio
- 0.07
Income Statement
In the last 12 months, Resonance Health Ltd had revenue of 15.75M and earned 1.51M in profits. Earnings per share was 0.00.
- Revenue
- 15.75M
- Gross Profit
- 14.80M
- Operating Income
- 1.53M
- Pretax Income
- 1.10M
- Net Income
- 1.51M
- EBITDA
- 2.48M
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was 2.88M and capital expenditures -94,768, giving a free cash flow of 2.79M billion.
- Operating Cash Flow
- 2.88M
- Free Cash Flow
- 2.79M
- Free Cash Flow per Share
- 0.01
Dividends & Yields
Resonance Health Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.40%
- Earnings Yield
- 3.45%
Stock Price Statistics
- Beta
- 1.71
- 52-Week Price Change
- 87.76%
- 50-Day Moving Average
- 0.07
- 200-Day Moving Average
- 0.05
- Relative Strength Index (RSI)
- 66.67
- Average Volume (3m)
- 615.84K
Important Dates
Resonance Health Ltd upcoming earnings date is Feb 19, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Feb 19, 2027
- Ex-Dividend Date
- ―
Financial Position
Resonance Health Ltd as a current ratio of 1.13, with Debt / Equity ratio of 34.29%
- Current Ratio
- 1.13
- Quick Ratio
- 1.13
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- -0.42
- Interest Coverage Ratio
- 4.52
Taxes
In the past 12 months, Resonance Health Ltd has paid -413.63K in taxes.
- Income Tax
- -413.63K
- Effective Tax Rate
- -0.38
Enterprise Valuation
Resonance Health Ltd EV to EBITDA ratio is 20.33, with an EV/FCF ratio of 18.13.
- EV to Sales
- 3.21
- EV to EBITDA
- 20.33
- EV to Free Cash Flow
- 18.13
- EV to Operating Cash Flow
- 17.54
Balance Sheet
Resonance Health Ltd has AUD 4.85M in cash and marketable securities with AUD 3.81M in debt, giving a net cash position of AUD 1.04M billion.
- Cash & Marketable Securities
- AUD 4.85M
- Total Debt
- AUD 3.81M
- Net Cash
- AUD 1.04M
- Net Cash Per Share
- AUD 0.00
- Tangible Book Value Per Share
- AUD 0.00
Margins
Gross margin is 93.95%, with operating margin of 9.72%, and net profit margin of 9.61%.
- Gross Margin
- 93.95%
- Operating Margin
- 9.72%
- Pretax Margin
- 6.98%
- Net Profit Margin
- 9.61%
- EBITDA Margin
- 15.77%
- EBIT Margin
- 9.72%
Analyst Forecast
The average price target for Resonance Health Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 42.25%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 8
- AI Score
- 71

